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Abstract
Background Patients with peritonitis undergoing emer-
gency laparotomy are at increased risk for postoperative
open abdomen and incisional hernia. This study aimed to
evaluate the outcome of prophylactic intraperitoneal mesh
implantation compared with conventional abdominal wall
closure in patients with peritonitis undergoing emergency
laparotomy.
Method A matched case-control study was performed. To
analyze a high-risk population for incisional hernia for-
mation, only patients with at least two of the following risk
factors were included: male sex, body mass index (BMI)
[25 kg/m2, malignant tumor, or previous abdominal
incision. In 63 patients with peritonitis, a prophylactic
nonabsorbable mesh was implanted intraperitoneally
between 2005 and 2010. These patients were compared
with 70 patients with the same risk factors and peritonitis
undergoing emergency laparotomy over a 1-year period
(2008) who underwent conventional abdominal closure
without mesh implantation.
Results Demographic parameters, including sex, age,
BMI, grade of intraabdominal infection, and operating time
were comparable in the two groups. Incidence of surgical
site infections (SSIs) was not different between groups
(61.9 vs. 60.3 %; p = 0.603). Enterocutaneous fistula
occurred in three patients in the mesh group (4.8 %) and in
two patients in the control group (2.9 %; p = 0.667). The
incidence of incisional hernia was significantly lower in the
mesh group (2/63 patients) than in the control group (20/70
patients) (3.2 vs. 28.6 %; p \ 0.001).
Conclusions Prophylactic intraperitoneal mesh can be
safely implanted in patients with peritonitis. It significantly
reduces the incidence of incisional hernia. The incidences
of SSI and enterocutaneous fistula formation were similar
to those seen with conventional abdominal closure.
Introduction
Patients undergoing emergency surgery for peritonitis are
at increased risk of abdominal wall-related complications.
The risk of incisional hernia in patients with peritonitis is
elevated, with an incidence of up to 54 %, compared with
an incidence of 11–26 % in the general surgical population
[1–3]. Furthermore, up to 24.1 % of patients with perito-
nitis undergoing emergency laparotomy may develop fas-
cial dehiscence [4].
Prophylactic mesh implantation has been shown to
reduce the incidence of incisional hernia in patients
undergoing vascular or bariatric procedures [5–7]. How-
ever, it remains unclear if nonabsorbable intraperitoneal
mesh implantation in an infected abdominal cavity is safe
because of the theoretical increased risk of chronic mesh
infection and enterocutaneous fistula [8–10].
In a previous study, we demonstrated the feasibility and
safety of nonresorbable intraperitoneal mesh placement in
patients with postoperative fascial dehiscence or an open
abdomen [11]. The present study aimed to evaluate the
safety and feasibility of prophylactic intraperitoneal mesh
implantation compared with conventional abdominal wall
closure in patients with peritonitis undergoing emergency
laparotomy.
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Methods
A matched case–control study was performed. To analyze a
high-risk population for incisional hernia formation, only
patients with at least two of the following risk factors were
included in the study: male sex, body mass index (BMI)
[25 kg/m2, malignant tumor, or previous abdominal
incision [12, 13]. Exclusion criteria were no clinical signs
of peritonitis, no midline incision, previous laparoscopic
surgery, presence of incisional hernia, open abdomen,
elective surgery, and previously implanted mesh. Between
2005 and 2010, prophylactic mesh implantation was per-
formed in 63 patients with peritonitis. Patient data were
prospectively collected in a database and analyzed retro-
spectively. In 2008, a total of 401 patients underwent
emergency operation at our institution. Among them, 70
patients (17.5 %) underwent conventional abdominal clo-
sure without mesh implantation, met the study inclusion
and exclusion criteria, and were used as a control group.
Clinical long-term follow-up investigations were per-
formed between September and December 2011 at our
institution by a single investigator who was not involved in
the medical care of the patients. In all, 27 patients (20.3 %)
died before the long-term follow-up investigation was
performed: 15 patients (23.8 %) in the mesh group and 12
patients (17.1 %) in the control group (p = 0.391). Four
patients (6.3 %) in the mesh group and four (2.9 %) in the
control group were lost to long-term follow-up. If the
patients were unwilling or unable to undergo ambulatory
consultations at the referral center (16/133; 12 %), their
general practitioners completed the clinical examinations
and filled out a questionnaire.
Surgical technique
For closure of the abdominal wall in the control group, a
standard technique was applied using a running suture of
PDS loop (Ethicon Sarl, Neuchatel, Switzerland). The
distance of the sutures to the fascial border was 1 cm, and
the distance between stitches was B1 cm. The total length
of the suturing was at least four times the total length of the
abdominal incision.
For abdominal wall closure in the mesh group, mesh
was implanted intraperitoneally prior to closure. The types
of nonabsorbable composite mesh used in 63 patients were
as follows: Parietene (Covidien AG, Wollerau, Switzer-
land) in 45 (71.4 %) patients; Parietex (Covidien AG) in 10
(15.9 %) patients; and Dynamesh (Laubscher, Ho¨lstein,
Switzerland) in 8 (12.7 %) patients. Meshes were placed
intraperitoneally and fixed with single knot fascial sutures
(Prolene 2-0; Ethicon Sarl), endosurgical staples (Protack;
Covidien AG), or a combination of the two. Meshes were
tailored to overlap lateral and cranial borders of the
incision by at least 5 cm. Afterward, the abdominal wall
was closed as described for the control group.
The primary outcome measure was incisional hernia.
The secondary outcome measures were an open abdomen,
surgical site infections (SSIs), enterocutaneous fistula,
mesh explantation, and hospital stay. SSIs were assessed up
to 30 days after surgery according to the criteria developed
by the Centers for Disease Control and Prevention [14].
Infections were categorized as incisional (superficial or
deep) or organ–space infections. Superficial SSIs involved
only skin and subcutaneous tissue and excluded stitch
abscesses. Deep SSIs involved deeper soft tissues, such as
fascia and muscle at the site of incision. Organ–space SSIs
were defined as infections in any organ or space. Con-
taminated wounds were defined as acute nonpurulent
infections and dirty wounds as having an active infection
present. An incisional hernia was defined as any abdominal
wall gap with or without a bulge in the area of a postop-
erative scar that was perceptible or palpable by clinical
examination or imaging.
Statistical analysis
Analysis was by intention to treat. Student’s t test was
performed to determine the significance between continu-
ous variables and Fisher’s exact test to compare propor-
tions. The p values were two-sided, and p\0.05 was used
as the threshold for statistical significance (NCSS 2007 for
Windows; NCSS, Kaysville, UT, USA).
Results
A total of 133 patients with peritonitis who underwent
emergency laparotomy fulfilled the inclusion and exclusion
criteria. Demographic parameters—including sex, age,
BMI, American Society of Anesthesiologists (ASA) score,
and co-morbidities—were not significantly different
between the two groups (Table 1). No difference was
found in the immunosuppression status between the two
groups. In the mesh group 11 of the 63 patients (17.5 %)
received immunosuppression therapy, as did 9 of the 70
patients (12.9 %) in the control group (p = 0.51). There
was a significant difference in the sum of risk factors for
incisional hernia between the mesh and control groups:
median 3 (range 2–4) versus 2 (2–4) (p = 0.013) (Table 2).
Table 3 reports the operative results. Grades of intra-
abdominal infection (dirty and contaminated) were com-
parable in the mesh and control groups (58.7/41.3 vs. 54.3/
45.7 %; (p = 0.726). Operating time and duration of hos-
pital stay were comparable in the two groups. In all, 22
patients (34.9 %) in the mesh group and 17 patients
(24.3 %) in the control group were treated on the intensive
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care unit postoperatively (p = 0.188). In four patients
(5.7 %) of the control group, mesh was implanted sec-
ondarily during reoperation for an open abdomen.
Table 4 reports outcome parameters. SSIs occurred in
30 patients (60.3 %) in the mesh group and 39 patients
(61.9 %) in the control group (p = 0.603). The incidence
of incisional hernia was significantly lower in the mesh
group (2/63 patients) compared with the control group (20/
70 patients) (3.2 vs. 28.6 %; p \ 0.001). Enterocutaneous
fistulas developed in three patients (4.8 %) in the mesh
group and in two patients (2.9 %) in the control group
(p = 0.667). One mesh was explanted in the mesh group
because of a lack of mesh incorporation secondary to
repeated reoperations for postoperative intraabdominal
hemorrhage. The 30-day mortality rate for patients with an
open abdomen was 20 % (1/5).
Discussion
Prophylactic intraperitoneal mesh implantation signifi-
cantly reduces the incidence of incisional hernia in patients
with peritonitis and is associated with a comparable rate of
SSIs and enterocutaneous fistula formation compared to
conventional abdominal closure. Abdominal wall-associ-
ated complications, such as fascial dehiscence and SSIs,
are frequent in patients undergoing surgical therapy for
peritonitis. Reinforcement of the abdominal wall with a
prophylactic intraperitoneal mesh implantation is a reliable
treatment strategy to reduce the incidence of incisional
hernia. The present study demonstrates a significantly
reduced incidence of incisional hernia in patients with
peritonitis undergoing prophylactic intraperitoneal mesh
implantation (3.2 vs. 28.6 %; p = 0.0001).
Few studies have explored the incidence of incisional
hernia. In a retrospective trial, the incidence of incisional
hernia was 54.3 % after a median follow-up of 6 years in
patients undergoing emergency surgery for secondary
peritonitis [1]. A lower incidence of 28.6 % was found in
our control group, which may have been due to a shorter
Table 1 Demographic parameters
Parameter Mesh group (n = 63) Control group (n = 70) p*
Age (years) 63 (22–84) 65 (21–90) 0.225**
Male/female 41/22 (65.1/34.9 %) 33/37 (47.1/52.9 %) 0.054
BMI (kg/m2) 26.5 (16.0–54.3) 25.8 (18.3–60) 0.711**
ASA score 3 (2–5) 4 (2–5) 0.079**
Co-morbidity
COPD 18 (28.6 %) 12 (17.1 %) 0.147
CHD 24 (38.1 %) 33 (47.1 %) 0.300
Diabetes 13 (20.6 %) 12 (17.1 %) 0.661
30-Day mortality 6 (9.5 %) 5 (7.1 %) 0.756
Results are medians (range) or the number of patients unless otherwise indicated
BMI body mass index, ASA american society of anesthesiologists, COPD chronic obstructive pulmonary disease, CHD coronary heart disease
*Fisher’s exact test unless otherwise indicated; **student’s t test
Table 2 Risk factors for incisional hernia
Risk factor Mesh group
(n = 63)
Control group
(n = 70)
p*
Male sex 41 (65.1 %) 33 (47.1 %) 0.054
BMI C25 kg/m2 36 (57.1 %) 32 (45.7 %) 0.225
Malignant tumor 28 (44.4 %) 32 (45.7 %) 1.000
Previous laparotomy 58 (92.1 %) 61 (87.1 %) 0.408
Total risk factors
(median and range)
3 (2–4) 2 (2–4) 0.013**
*Fisher’s exact test unless otherwise indicated; **student’s t test
Table 3 Details of operative procedures
Surgical
parameter
Mesh group
(n = 63)
Control group
(n = 70)
p*
Abdominal cavity
Dirty 37 (58.7 %) 38 (54.3 %) 0.726
Contaminated 26 (41.3 %) 32 (45.7 %) 0.726
Type of surgery
Upper GI tract 13 (20.6 %) 13 (18.6 %) 0.829
Lower GI tract 40 (63.5 %) 51 (72.9 %) 0.837
HPB 6 (9.5 %) 3 (4.3 %) 0.307
Other 4 (6.3 %) 3 (4.3 %) 0.307
Operating time
(min)
145 (50–665) 180 (60–540) 0.515**
Hospital stay
(days)
20 (5–91) 17 (6–194) 0.613**
Results are number of patients or the median (range)
GI gastrointestinal, HPB hepatopancreaticobiliary
*Fisher’s exact test unless indicated otherwise; **student’s t test
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duration of follow-up. Prophylactic mesh implantation did
not prevent incisional hernia completely in the present
study. Incisional hernia was observed in two patients
(3.2 %) despite prophylactic mesh implantation. Potential
explanations include insufficient mesh fixation or implan-
tation of an undersized mesh. Subgroup analysis showed no
difference in the incidence of incisional hernia or SSIs with
respect to the different meshes and types of fixation.
However, we acknowledge a potential type two error with
regard to the small size of the subgroups.
No patient with prophylactic mesh implantation had
postoperative open abdomen compared to 5 of 70 patients
(7.1 %) in the control group. This difference is not statis-
tically significant.
Complications associated with mesh implantation in
patients with peritonitis include SSIs and enterocutaneous
fistulas with or without mesh explantation. In the present
study, no statistically significant difference regarding the
appearance of SSIs was found between patients with and
without mesh implantation. No mesh explantations were
performed because of chronic infection. SSIs were treated
with local therapy, including wound dressing or vacuum-
assisted therapy, in both groups.
A relevant difference between this study and previous
case series is the mesh material used and the intraperitoneal
position of the mesh. Polypropylene-based meshes are
associated with significantly reduced ingrowths of bacteria
compared to polyester and polytetrafluoroethylene (PTFE)-
based meshes [15]. Biofilm produced by gram-positive
bacteria provides protection against bacteria only in
meshes with large surfaces, such as PTFE, and is thereby
associated with chronic infection [15]. The second putative
reason for the absence of chronic infection in our series is
the mesh placement within the abdominal cavity and not in
a preperitoneal space. Unlike preperitoneal tissue, when
placed in the abdominal cavity the mesh is in direct contact
with peritoneal macrophages and granulocytes, which
immediately remove necrotic tissue and initiate a humoral
and cellular immune response [16, 17]. In a previous study,
mesh implantation in clean-contaminated and contami-
nated ventral hernia repairs was associated with increased
postoperative complications [18]. This study, however, has
a selection bias, as the database analyzed did not allow the
authors to correct for the indication of mesh implantation
[18]. Furthermore, specific mesh-associated complica-
tions—e.g., mesh explantation and enterocutaneous fis-
tula—were not described in detail [18].
A limitation of the present study is lack of randomiza-
tion. Intraperitoneal mesh implantation was performed in
selected high-risk patients. Despite being at higher risk,
however, the incidence of incisional hernia was reduced in
the treatment group at long-term follow-up.
Conclusions
Prophylactic intraperitoneal mesh implantation in patients
with peritonitis should be considered as a therapeutic
option to reduce significantly the incidence of incisional
hernia. The low incidence of enterocutaneous fistula and
mesh explantation seems to justify a prophylactic proce-
dure to prevent a frequent complication such as incisional
hernia even in patients with an infected abdomen. Ran-
domized, controlled trials are warranted to confirm the
safety of prophylactic intraperitoneal mesh placement in
the infected abdominal cavity.
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